# Andersen Group Inc.: financial statements, quarterly

ANDG · NYSE · CIK 2065708 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/andg.md) · [Financials](/companies/andg/financials.md) · [Filings](/companies/andg/filings.md) · [Insiders](/companies/andg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/andg/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $m | [208](/filings/0001193125-26-219544.md) | [176](/filings/0001193125-26-346921.md) | [241](/filings/0001193125-26-219544.md) | [218](/filings/0001193125-26-346921.md) |
| Selling, general and administrative | $m | [35.4](/filings/0001193125-26-219544.md) | [53.9](/filings/0001193125-26-346921.md) | [48.0](/filings/0001193125-26-219544.md) | [50.5](/filings/0001193125-26-346921.md) |
| Operating income | $m | [52.6](/filings/0001193125-26-219544.md) | [(105)](/filings/0001193125-26-346921.md) | [24.1](/filings/0001193125-26-219544.md) | [(8.9)](/filings/0001193125-26-346921.md) |
| Interest expense | $m | [0.1](/filings/0001193125-26-219544.md) | [0.1](/filings/0001193125-26-346921.md) | [6.2](/filings/0001193125-26-219544.md) | [5.9](/filings/0001193125-26-346921.md) |
| Income tax | $m | [4.1](/filings/0001193125-26-219544.md) | [(7.0)](/filings/0001193125-26-346921.md) | [2.8](/filings/0001193125-26-219544.md) | [(0.1)](/filings/0001193125-26-346921.md) |
| Net income | $m | [50.6](/filings/0001193125-26-219544.md) | [(96.0)](/filings/0001193125-26-346921.md) | [0.5](/filings/0001193125-26-219544.md) | [(1.0)](/filings/0001193125-26-346921.md) |
| Diluted EPS | $ per share | not reported | not reported | [0.03](/filings/0001193125-26-219544.md) | [(0.09)](/filings/0001193125-26-346921.md) |
| Basic EPS | $ per share | not reported | not reported | [0.04](/filings/0001193125-26-219544.md) | [(0.08)](/filings/0001193125-26-346921.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-12-31) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [88.0](/filings/0001193125-26-128949.md) | [250](/filings/0001193125-26-346921.md) | [207](/filings/0001193125-26-219544.md) | [176](/filings/0001193125-26-346921.md) |
| Current assets | $m | [246](/filings/0001193125-26-128949.md) | [412](/filings/0001193125-26-346921.md) | [454](/filings/0001193125-26-219544.md) | [405](/filings/0001193125-26-346921.md) |
| Total assets | $m | [399](/filings/0001193125-26-128949.md) | [565](/filings/0001193125-26-346921.md) | [609](/filings/0001193125-26-219544.md) | [571](/filings/0001193125-26-346921.md) |
| Current liabilities | $m | [94.4](/filings/0001193125-26-128949.md) | [196](/filings/0001193125-26-346921.md) | [192](/filings/0001193125-26-219544.md) | [185](/filings/0001193125-26-346921.md) |
| Total liabilities | $m | [202](/filings/0001193125-26-128949.md) | [594](/filings/0001193125-26-346921.md) | [580](/filings/0001193125-26-219544.md) | [540](/filings/0001193125-26-346921.md) |
| Long-term debt | $m | not reported | [350](/filings/0001193125-26-128949.md) | [336](/filings/0001193125-26-219544.md) | [301](/filings/0001193125-26-346921.md) |
| Shareholders' equity | $m | not reported | [(135)](/filings/0001193125-26-346921.md) | [(780)](/filings/0001193125-26-219544.md) | [(775)](/filings/0001193125-26-346921.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [11.2](/filings/0001193125-26-219544.md) | [50.6 d](/filings/0001193125-26-346921.md) | [(3.9)](/filings/0001193125-26-219544.md) | [69.7 d](/filings/0001193125-26-346921.md) |
| Capital expenditure | $m | [1.3](/filings/0001193125-26-219544.md) | [1.6 d](/filings/0001193125-26-346921.md) | [3.7](/filings/0001193125-26-219544.md) | [9.1 d](/filings/0001193125-26-346921.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [14.8](/filings/0001193125-26-219544.md) | [13.3](/filings/0001193125-26-346921.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.